0
     

Report Added
Report already added
North America Healthcare Cybersecurity Market 2021-2031 by Offering (Solutions, Services), Threat Type (Malware, DDoS, APT, Spyware, Others), Security Type (Network, Cloud, Application, Endpoint), Deployment Mode (On-premise, Cloud-based), End User (Pharma & Biotech Companies, Healthcare Payers, Hospitals, Others), and Country: Trend Forecast and Growth Opportunity

North America Healthcare Cybersecurity Market 2021-2031 by Offering (Solutions, Services), Threat Type (Malware, DDoS, APT, Spyware, Others), Security Type (Network, Cloud, Application, Endpoint), Deployment Mode (On-premise, Cloud-based), End User (Pharma & Biotech Companies, Healthcare Payers, Hospitals, Others), and Country: Trend Forecast and Growth Opportunity

North America healthcare cybersecurity market is projected to grow by 16.2% annually in the forecast period and reach $ 21,084.7 million by 2031, driven by the emergence of digital technologies in healthcare sector, the rising incidences and complexity of cyberattacks, the growing concern on data privacy and safety, continuous technological advancements in healthcare cybersecurity, and the collaboration between private and public sectors to strengthen cybersecurity.
Highlighted with 27 tables and 58 figures, this 113-page report “North America Healthcare Cybersecurity Market 2021-2031 by Offering (Solutions, Services), Threat Type (Malware, DDoS, APT, Spyware, Others), Security Type (Network, Cloud, Application, Endpoint), Deployment Mode (On-premise, Cloud-based), End User (Pharma & Biotech Companies, Healthcare Payers, Hospitals, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America healthcare cybersecurity market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America healthcare cybersecurity market in every aspect of the classification from perspectives of Offering, Threat Type, Security Type, Deployment Mode, End User, and Country.

Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Solutions
oRisk and Compliance Management
oAntivirus and Antimalware
oIdentity and Access Management
oSecurity Information and Event Management (SIEM)
oIntrusion Detection System (IDS)/Intrusion Prevention System (IPS)
oDistributed Denial of Service (DDoS) Mitigation
oOther Types of Solutions
•Services
oDeployment & Integration
oSupport & Maintenance
oTraining & Consulting
oManaged Security Services

Based on Threat Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Malware
oRansomware
oVirus
oOther Malwares
•Distributed Denial of Service (DDoS)
•Advanced Persistent Threats (APT)
•Spyware
•Other Threat Types

By Security Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Network Security
•Cloud Security
•Application Security
•Endpoint Security

By Deployment Mode, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•On-Premise Platforms
•Cloud-Based Platforms

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Pharma & Biotech Companies
•Healthcare Payers
•Hospitals
•Other End Users

Geographically, the following national/local markets are fully investigated:
•U.S.
•Canada
•Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Threat Type, Security Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Broadcom Inc. (Symantec)
Cisco Systems Inc.
FireEye Inc. (Symphony Technology Group)
Fortinet Inc.
IBM Corporation
Imperva Inc.
Intel Corporation
Kaspersky Labs Inc.
McAfee Inc.
Medigate Ltd (Claroty)
Palo Alto Networks, Inc.
Trend Micro Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy20
2.1.2 Impact of COVID-19 on the Market24
2.2 Major Growth Drivers26
2.3 Market Restraints and Challenges32
2.4 Emerging Opportunities and Market Trends35
2.5 Porter’s Fiver Forces Analysis39
3 Segmentation of North America Market by Offering43
3.1 Market Overview by Offering43
3.2 Solutions45
3.2.1 Risk and Compliance Management47
3.2.2 Antivirus and Antimalware48
3.2.3 Identity and Access Management49
3.2.4 Security Information and Event Management (SIEM)50
3.2.5 Intrusion Detection System (IDS)/Intrusion Prevention System (IPS)51
3.2.6 Distributed Denial of Service (DDoS) Mitigation52
3.2.7 Other Types of Solutions53
3.3 Services54
3.3.1 Deployment & Integration56
3.3.2 Support & Maintenance57
3.3.3 Training & Consulting58
3.3.4 Managed Security Services59
4 Segmentation of North America Market by Threat Type60
4.1 Market Overview by Threat Type60
4.2 Malware62
4.2.1 Ransomware63
4.2.2 Virus64
4.2.3 Other Malwares65
4.3 Distributed Denial of Service (DDoS)66
4.4 Advanced Persistent Threats (APT)67
4.5 Spyware68
4.6 Other Threat Types69
5 Segmentation of North America Market by Security Type70
5.1 Market Overview by Security Type70
5.2 Network Security72
5.3 Cloud Security73
5.4 Application Security74
5.5 Endpoint Security75
6 Segmentation of North America Market by Deployment Mode76
6.1 Market Overview by Deployment Mode76
6.2 On-Premise Platforms78
6.3 Cloud-Based Platforms79
7 Segmentation of North America Market by End User80
7.1 Market Overview by End User80
7.2 Pharma & Biotech Companies82
7.3 Healthcare Payers83
7.4 Hospitals84
7.5 Other End Users85
8 North America Market 2021-2031 by Country86
8.1 Overview of North America Market86
8.2 U.S.89
8.3 Canada92
8.4 Mexico94
9 Competitive Landscape96
9.1 Overview of Key Vendors96
9.2 New Product Launch, Partnership, Investment, and M&A99
9.3 Company Profiles100
Broadcom Inc. (Symantec)100
Cisco Systems Inc.102
FireEye Inc. (Symphony Technology Group)103
Fortinet Inc.104
IBM Corporation105
Imperva Inc.106
Intel Corporation107
Kaspersky Labs Inc.108
McAfee Inc.109
Medigate Ltd (Claroty)110
Palo Alto Networks, Inc.111
Trend Micro Inc.112
RELATED REPORTS113List of Tables:

Table 1. Snapshot of North America Healthcare Cybersecurity Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203121
Table 3. World Economic Outlook, 2021-202322
Table 4. Worldwide Number of Healthcare Data Breaches with Loss of 500 or More Records29
Table 5. World Health Spending by Region, $ bn, 2013-202031
Table 6. Main Product Trends and Market Opportunities in North America Healthcare Cybersecurity Market35
Table 7. North America Healthcare Cybersecurity Market by Offering, 2021-2031, $ mn43
Table 8. North America Healthcare Cybersecurity Market: Solutions by Type, 2021-2031, $ mn46
Table 9. North America Healthcare Cybersecurity Market: Services by Type, 2021-2031, $ mn55
Table 10. North America Healthcare Cybersecurity Market by Threat Type, 2021-2031, $ mn60
Table 11. North America Healthcare Cybersecurity Market: Malware by Type, 2021-2031, $ mn62
Table 12. North America Healthcare Cybersecurity Market by Security Type, 2021-2031, $ mn70
Table 13. North America Healthcare Cybersecurity Market by Deployment Mode, 2021-2031, $ mn76
Table 14. North America Healthcare Cybersecurity Market by End User, 2021-2031, $ mn80
Table 15. North America Healthcare Cybersecurity Market by Country, 2021-2031, $ mn87
Table 16. U.S. Healthcare Cybersecurity Market by Threat Type, 2021-2031, $ mn91
Table 17. U.S. Healthcare Cybersecurity Market by Security Type, 2021-2031, $ mn91
Table 18. U.S. Healthcare Cybersecurity Market by End User, 2021-2031, $ mn91
Table 19. Canada Healthcare Cybersecurity Market by Threat Type, 2021-2031, $ mn93
Table 20. Canada Healthcare Cybersecurity Market by Security Type, 2021-2031, $ mn93
Table 21. Canada Healthcare Cybersecurity Market by End User, 2021-2031, $ mn93
Table 22. Mexico Healthcare Cybersecurity Market by Threat Type, 2021-2031, $ mn95
Table 23. Mexico Healthcare Cybersecurity Market by Security Type, 2021-2031, $ mn95
Table 24. Mexico Healthcare Cybersecurity Market by End User, 2021-2031, $ mn95
Table 25. Broadcom Inc.: Company Snapshot100
Table 26. Broadcom Inc.: Business Segmentation101
Table 27. Broadcom Inc.: Product Portfolio101

Report Title: North America Healthcare Cybersecurity Market 2021-2031 by Offering (Solutions, Services), Threat Type (Malware, DDoS, APT, Spyware, Others), Security Type (Network, Cloud, Application, Endpoint), Deployment Mode (On-premise, Cloud-based), End User (Pharma & Biotech Companies, Healthcare Payers, Hospitals, Others), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM